BioSpace News Archive

AbbVie (NYSE: ABBV) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for VENCLYXTO® (venetoclax) in combination with hypomethylating agents for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy.

Spacelabs Healthcare, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS), announced today that it has been awarded a three-year Premier agreement for physiological patient monitoring and non-invasive cardiology solutions.

Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its American Depositary Shares, representing common shares, in the United States.